EP2271280A1 - Covered stent and method of making - Google Patents
Covered stent and method of makingInfo
- Publication number
- EP2271280A1 EP2271280A1 EP09728421A EP09728421A EP2271280A1 EP 2271280 A1 EP2271280 A1 EP 2271280A1 EP 09728421 A EP09728421 A EP 09728421A EP 09728421 A EP09728421 A EP 09728421A EP 2271280 A1 EP2271280 A1 EP 2271280A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- substrate
- stent
- covered stent
- interwoven
- covered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 239000000758 substrate Substances 0.000 claims abstract description 88
- 238000005538 encapsulation Methods 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 19
- 238000001523 electrospinning Methods 0.000 claims description 17
- 238000003618 dip coating Methods 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 10
- 230000017531 blood circulation Effects 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims 1
- 238000010276 construction Methods 0.000 description 11
- 239000012528 membrane Substances 0.000 description 7
- 206010002329 Aneurysm Diseases 0.000 description 6
- 238000004873 anchoring Methods 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229920004934 Dacron® Polymers 0.000 description 2
- 208000002223 abdominal aortic aneurysm Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000013047 polymeric layer Substances 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- 229920000271 Kevlar® Polymers 0.000 description 1
- 229920000106 Liquid crystal polymer Polymers 0.000 description 1
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 1
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000003090 iliac artery Anatomy 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004761 kevlar Substances 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 230000002966 stenotic effect Effects 0.000 description 1
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
Definitions
- the invention relates to encapsulated stents suitable for placement in a human body lumen such as an artery.
- Tubular prostheses such as stents, grafts, and stent-grafts (e.g., stents having an inner and/or outer covering comprising graft material and which may be referred to as covered stents) have been used to treat abnormalities in passageways in the human body.
- these devices often are used to replace or bypass occluded, diseased or damaged blood vessels such as stenotic or aneurysmal vessels.
- stent-grafts which comprise biocompatible graft material (e.g., Dacron ® or expanded polytetrafluoroethylene (ePTFE) or some other polymer) supported by a framework (e.g., one or more stent or stent-like structures), to treat or isolate aneurysms.
- the framework provides mechanical support and the graft material or liner provides a blood barrier.
- Aneurysms are an abnormal widening of a duct or canal such as a blood vessel and generally appear in the form of a sac formed by the abnormal dilation of the duct or vessel wall.
- the abnormally dilated wall typically is weakened and susceptible to rupture.
- Aneurysms can occur in blood vessels such as in the abdominal aorta where the aneurysm generally extends from a location below the renal arteries distally to or toward the iliac arteries.
- the stent-graft In treating an aneurysm with a stent-graft, the stent-graft typically is placed so that one end of the stent-graft is situated proximally or upstream of the diseased portion of the vessel and the other end of the stent-graft is situated distally or downstream of the diseased portion of the vessel. In this manner, the stent-graft extends through (spans) the aneurysmal sac and beyond the proximal and distal ends thereof to replace or bypass the weakened portion.
- the graft material typically forms a blood impervious lumen to facilitate endovascular exclusion of the aneurysm.
- stent-grafts such as abdominal aortic aneurysm stent- grafts
- sewing annular metallic spring elements which may have a sinusoidal configuration, to woven materials described above such as expanded polytetrafluoroethylene, polytetrafluoroethylene, or Dacron ® fabric.
- Other approaches have included electrospinning the stent structure with a polymer or dip coating the stent structure with a polymer.
- FIG. 1 One example of a known polymeric coated stent-graft is illustrated in FIG. 1 , where covered stent 100 comprises metallic springs or undulating elements 102a, 102b, 102c and 102d, which can be referred to as stents or stent elements.
- stents or stent elements 102a, 102b, 102c and 102d have been treated with an electrospinning or dip coating process to form tubular polymeric graft member 104, which is adhered thereto.
- electrospinning and dip coating techniques may provide stent-grafts with lower profiles, there is a relatively low contact surface area between the stents and the polymeric material and the line of contact or adhesion between the stent and the polymeric material also may not be uniform throughout the circumference of the stent resulting in non-uniform load distribution when a force is placed on the stent-graft, which can result in delamination.
- FIG. 2 illustrates a covered stent 110 having a known construction including a plurality of metallic undulating annular stent elements 112a, 112b, 112c ...112n and annular undulating bare wire spring 116.
- a known electrospinning or dip coating process is used to provide the stent elements with a tubular polymeric graft 114 and to secure the apexes at one end of bare spring 116 to the graft.
- the apexes which can be subjected to higher stresses than the stent elements, can detach as diagrammatically shown for example with reference character D2.
- a covered stent suitable for placement in a lumen in a human body comprises a substrate; a tubular stent adapted to be placed in a lumen of a human body, the stent having portions interwoven in the substrate; and encapsulation encapsulating the substrate and the portions of the stent interwoven in the and forming tubular graft member.
- a covered stent suitable for placement in a lumen in a human body comprises a substrate; a plurality of stents adapted to be placed in a lumen of a human body, the stents having portions interwoven in the substrate; and a tubular polymeric member covering the stents and extending through at least a portion of the substrate.
- a method of making a covered stent comprises interweaving a wire though a substrate to form a tubular member; and encapsulating the tubular member to form a covered stent having a tubular cover.
- FIG. 1 illustrates a known covered stent configuration.
- FIG. 2 illustrates a portion of another known covered stent configuration.
- FIG. 3A is a cut away view of a covered stent embodiment according to the invention with a portion of the cover removed to show a stent element and a substrate in which it is integrated.
- FIG. 3B1 is a sectional view taken along line 3B1-3B1 in FIG. 3A and diagrammatically illustrating locations in the tubular substrate where the annular stent is interwoven.
- FIG. 3B2 is a sectional view taken through a portion of one of the stents of FIG. 3A showing the substrate and cover material
- FIG. 3C is a close up view illustrating a variation of the substrate-stent configuration shown in FIG. 3A.
- FIG. 3D is a close up view illustrating another variation of the substrate-stent configuration shown in FIG. 3A.
- FIG. 4 is a close up view illustrating a stent-graft substrate and a bare wire spring integrated therein according to another embodiment of the invention.
- FIG. 5A illustrates a known anchoring mechanism.
- FIG. 5B illustrates a portion of a covered stent with the anchoring mechanism of FIG. 5A integrated therein.
- FIG. 6 is a partial sectional view of a portion of a covered stent with an anchor element secured thereto.
- FIG. 7 is a partial sectional view of a portion of a covered stent with an anchor element secured thereto.
- FIGS. 8A and 8B illustrate assembly of another covered stent embodiment according to the invention, where FIG. 8A illustrates an anchoring attachment component for the covered stent and FIG. 8B illustrates the anchoring attachment component integrally formed in a covered stent according to another embodiment.
- the invention generally involves a method of incorporating one or more stent and/or anchor structures into a polymeric membrane, which can be formed, for example, through known electrospinning or dip coating techniques.
- the stent or stents or at least a portion thereof are integrally incorporated into a material, which can be referred to as a substrate, and the integrated construction partially or wholly encapsulated (e.g., in a polymer such as polyurethane) by known electrospinning or dip coating techniques.
- the substrate material can be loose textile mesh constructed from an open weave, knit, or braid.
- the textile mesh should be sufficiently open to easily allow the polymer to flow through it during the electrospinning or dip coating process.
- incorporating or integrating the stent into the substrate material can be accomplished by passing an end of the stent wire back and forth through mesh in an annular direction and then crimping the free ends of the wire together to form an annular stent element. All of the wire need not be weaved in and out of the mesh as will be described in more detail below.
- Other methods of integrating the stent and mesh material include weaving or knitting the mesh around the entire stent or at least a portion of the stent.
- the integrated stent-substrate construction is then encapsulated or coated using, for example, a known stent electrospinning or dip coating process, to form the polymeric membrane stent cover.
- the stent cover provides a fluid barrier that is suitable as for use as a graft in a lumen in a human patient. Typically the cover will provide a continuous blood impervious surface suitable for use in an artery in a human patient.
- One of the many advantages of this construction is that if the stent becomes completely delaminated from the polymeric membrane formed with the foregoing process, it remains attached by the polymer mesh (polymer mesh is a loose weave, braid, or knit.
- the substrate or mesh can better distribute the load of the stent through the membrane as compared to a stent without such a substrate.
- the polymeric material also can be selected to improve the bonding or adhesion between the stent-substrate and the polymeric material.
- the mesh substrate has a loose construction suitable for weaving the stent wire in and out of the substrate. It can be a very open weave, knit or braid. Knitted meshes typically offer more flexibility and weaves typically offer more dimensional stability.
- the substrate mesh can be made from a variety of materials including polyester, UHMWPE, liquid crystal polymers, and Kevlar.
- covered stent 200 is shown with three stents 202a, 202b and 202c. It should be understood, however, that more or fewer stents can be used.
- the stents are shown with undulating annular configurations where each undulation has two leg portions which converge at an apex. The number of undulations can vary depending on the size of the stent and the application and in this example there are four undulations where two are hidden from view.
- one of each of the two leg portions is interwoven into the material and the other is not woven into the material and is adjacent to the inner surface or outer surface of mesh substrate 206.
- FIG. 3A depicts descending legs 208a and 208b interwoven in mesh substrate 206 in which appears as dashed lines, while ascending legs 209a and 209b are shown positioned along the outer surface of the substrate.
- the other undulating portions are similarly integrated with mesh substrate 206, but hidden from view.
- every other leg is interwoven into the substrate when moving in an annular or circumferential direction as diagrammatically shown in FIG. 3B1.
- FIG. 3C an oppositely configured pattern is used.
- Legs 209a, 209b, and 209c are interwoven into mesh substrate 206, while legs 208a, 208b, 208c are outside the mesh substrate prior to electrospinning or dip coating (the remaining legs forming the annular stent are hidden from view.
- all legs of each undulation are interwoven into the mesh substrate before electrospinning or dip coating (five legs are shown in this figure with the remaining legs forming the annular stent being hidden from view).
- FIG. 3B2 a sectional view of a portion of stent 200 is shown depicting stent wire 202c between two layers of polymeric material 204 on opposite sides of the mesh substrate.
- the mesh substrate is sufficiently open so as to allow the polymer to pass therethrough during the electrospinning or dip coating process.
- FIG. 4 another embodiment is shown where undulating bare spring wire 510 is integrated with mesh substrate 506 before electrospinning or dip coating.
- the apex portions at one end of the bare spring are interwoven in mesh substrate 506.
- the apex portions are shown encircled and numbered 512a, 512b, and 512c.
- Stent elements can be provided as described in any of the embodiments disclosed herein.
- FIG. 5A depicts a known stent-graft anchor 600 having a barb support member or cage 602 with a plurality of barbs 604a,b,c,d extending from or secured to end portions along one side thereof.
- Wires or posts 606a,b,c,d having eyelets or loops 608a,b,c,d at their free ends extend from or are attached to the other side of the cage.
- the anchor is secured to covered stent 650 having one or more stents 652 integrated therein using a substrate as described above.
- the anchor is secured to the substrate with a plurality of high strength filaments 654a,b...n that are looped through eyelets 608a,b...n.
- the filaments are interwoven in the substrate along a portion of the length of the substrate such as shown in detail in FIG. 6 before the stent, substrate and eyelets are encapsulated in a polymer by way of, for example, an electrospinning or dip coating process to provide a tubular covered stent that is impervious to blood flow through the tubular cover.
- the substrate can run the entire length of the covered stent in this embodiment or any other embodiment described herein and the filaments can be interwoven along the entire length of the substrate to maximize filament incorporation or integration with the cover or polymeric membrane 656, which can comprise, for example, any of the materials described above.
- the substrate need not run the entire length of the covered stent and the filaments need not extend the entire length of the substrate.
- the free ends of the filament can be adhered, tied otherwise secured to the substrate.
- Anchor 600 and the bare springs described below typically are attached to the proximal end of the covered stent, which is the end closest to the heart by reference to blood flow path when the covered stent is positioned in situ.
- FIG. 6 another covered stent embodiment 700 is shown where a bare coil spring 750 with posts 752a,b,c...n extending therefrom and including eyelets 754a,b,c...n is secured to the covered stent in the same manner as anchor 600 is secured to covered stent 650.
- Each of a plurality of high strength filaments 756a,b...n, each of which can be a high strength fiber, are passed through a respective eyelet and interwoven in the mesh substrate that extends the entire length and the entire circumference of the covered stent.
- Covered stent 700 is shown in partial section with a portion of polymeric layer or cover 757 removed to show a portion of substrate 758 in an enlarged manner to illustrate filament 756b interwoven therein.
- Substrate 758 has a plurality of interwoven threads that can be interlaced like the warp and weft of a woven fabric. It should be understood that mesh patterns in all of the embodiments described herein are interchangeable and further that other patterns can be used as the illustrative embodiments are provided for the purposes of example and not to limit the scope of of possible options.
- Covered stent 700 also includes one or more stents 780 which can have the same configuration as stents 202a-c and can be interwoven into mesh substrate 758 in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206.
- FIG. 7 another covered embodiment 800, which is the same as covered stent 700 with the exception that the securing filament pattern differs.
- Bare spring 850 can have the same construction as bare spring 750 with eyelets 854a,b,c...n through which high strength filaments 856a,b,c...n are passed.
- Filaments 856a, b, c... n are interwoven in substrate 858, which can have the same construction as substrate 758 or any other suitable substrate.
- Covered stent 800 is shown in partial section with a portion of polymeric layer or cover 857 removed to show a portion of substrate 858 in an enlarged manner to illustrate filaments 856a and 856c interwoven therein.
- each filament has one portion that extends in a clockwise helical direction and another portion that extends in a counterclockwise helical direction.
- the filaments in this embodiment can improve load distribution from the eyelets.
- covered stent 800 also includes one or more stents, which can have the same configuration as stents 202a-c and can be interwoven into mesh substrate 858 in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206.
- FIGS. 8A and 8B another covered stent embodiment 900 according to the invention is shown, where FIG. 8A illustrates an anchor and attachment component of covered stent 900 and FIG.
- bare spring 950 has the same construction as bare spring 750 and includes eyelets 954a,b,c...n through which a single high strength filament 956 is passed.
- Filament 956, which can be a high strength fiber, is interwoven in annular substrate 958, which can have the same construction as substrate 758 or any other suitable substrate.
- Annular substrate 958 can then be coupled to a tubular substrate such as substrate 206.
- Covered stent 800 also includes one or more stents 980, which can have the same configuration as stents 202a-c and can be interwoven into the mesh substrate to which substrate 958 is coupled in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206.
- the stent, bare spring, and substrate assembly is then encapsulated with a polymer using any suitable process such as electrospinning or dip coating.
- any of the covered stents described herein can have a bifurcated configuration suitable for treating abdominal aortic aneurysms.
- Any feature described in any one embodiment described herein can be combined with any other feature or features of any of the other embodiments or features described herein.
- variations and modifications of the devices and methods disclosed herein will be readily apparent to persons skilled in the art.
Landscapes
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
A covered stent comprises a substrate, a stent adapted to be placed in a lumen of a human body, where the stent has portions interwoven in the substrate, and encapsulation encapsulating the substrate and the portions of the stent interwoven in the substrate and forming a tubular graft member
Description
COVERED STENT AND METHOD OF MAKING SAME
FIELD OF THE INVENTION
[0001] The invention relates to encapsulated stents suitable for placement in a human body lumen such as an artery.
BACKGROUND OF THE INVENTION
[0002] Tubular prostheses such as stents, grafts, and stent-grafts (e.g., stents having an inner and/or outer covering comprising graft material and which may be referred to as covered stents) have been used to treat abnormalities in passageways in the human body. In vascular applications, these devices often are used to replace or bypass occluded, diseased or damaged blood vessels such as stenotic or aneurysmal vessels. For example, it is well known to use stent-grafts, which comprise biocompatible graft material (e.g., Dacron® or expanded polytetrafluoroethylene (ePTFE) or some other polymer) supported by a framework (e.g., one or more stent or stent-like structures), to treat or isolate aneurysms. The framework provides mechanical support and the graft material or liner provides a blood barrier. [0003] Aneurysms are an abnormal widening of a duct or canal such as a blood vessel and generally appear in the form of a sac formed by the abnormal dilation of the duct or vessel wall. The abnormally dilated wall typically is weakened and susceptible to rupture. Aneurysms can occur in blood vessels such as in the abdominal aorta where the aneurysm generally extends from a location below the renal arteries distally to or toward the iliac arteries.
[0004] In treating an aneurysm with a stent-graft, the stent-graft typically is placed so that one end of the stent-graft is situated proximally or upstream of the diseased portion of the vessel and the other end of the stent-graft is situated distally or downstream of the diseased portion of the vessel. In this manner, the stent-graft extends through (spans) the aneurysmal sac and beyond the proximal and distal ends thereof to replace or bypass the weakened portion. The graft material typically forms a blood impervious lumen to facilitate endovascular exclusion of the aneurysm. [0005] Approaches for making stent-grafts such as abdominal aortic aneurysm stent- grafts have included sewing annular metallic spring elements, which may have a sinusoidal configuration, to woven materials described above such as expanded polytetrafluoroethylene, polytetrafluoroethylene, or Dacron® fabric. Other approaches have included electrospinning the stent structure with a polymer or dip coating the
stent structure with a polymer. One example of a known polymeric coated stent-graft is illustrated in FIG. 1 , where covered stent 100 comprises metallic springs or undulating elements 102a, 102b, 102c and 102d, which can be referred to as stents or stent elements. In this example, stents or stent elements 102a, 102b, 102c and 102d have been treated with an electrospinning or dip coating process to form tubular polymeric graft member 104, which is adhered thereto. Although electrospinning and dip coating techniques may provide stent-grafts with lower profiles, there is a relatively low contact surface area between the stents and the polymeric material and the line of contact or adhesion between the stent and the polymeric material also may not be uniform throughout the circumference of the stent resulting in non-uniform load distribution when a force is placed on the stent-graft, which can result in delamination. The materials used also can be a factor in creating a tendency for the polymeric membrane and stent to delaminate. An example of separation or detachment between the stent wire and polymeric membrane is diagrammatically depicted and designated with reference character D1 in FIG. 1. Delamination typically is more of a concern in areas of higher stress loading such as the connections between the polymeric graft material and bare spring that extend beyond the edge of the polymeric graft material as shown in FIG. 2. FIG. 2 illustrates a covered stent 110 having a known construction including a plurality of metallic undulating annular stent elements 112a, 112b, 112c ...112n and annular undulating bare wire spring 116. A known electrospinning or dip coating process is used to provide the stent elements with a tubular polymeric graft 114 and to secure the apexes at one end of bare spring 116 to the graft. In this example, the apexes, which can be subjected to higher stresses than the stent elements, can detach as diagrammatically shown for example with reference character D2. [0006] There remains a need to develop and/or improve stent-graft constructions.
SUMMARY OF THE INVENTION
[0007] The present invention involves improvements in covered stent construction. [0008] In one embodiment according to the invention, a covered stent suitable for placement in a lumen in a human body (e.g., an artery) comprises a substrate; a tubular stent adapted to be placed in a lumen of a human body, the stent having portions interwoven in the substrate; and encapsulation encapsulating the substrate and the portions of the stent interwoven in the and forming tubular graft member.
[0009] In another embodiment according to the invention, a covered stent suitable for placement in a lumen in a human body comprises a substrate; a plurality of stents adapted to be placed in a lumen of a human body, the stents having portions interwoven in the substrate; and a tubular polymeric member covering the stents and extending through at least a portion of the substrate.
[0010] In another embodiment according to the invention, a method of making a covered stent comprises interweaving a wire though a substrate to form a tubular member; and encapsulating the tubular member to form a covered stent having a tubular cover.
[0011] The above is a brief description of some deficiencies in the prior art and advantages of embodiments according to the present invention. Other features, advantages, and embodiments according to the present invention will be apparent to those skilled in the art from the following description and accompanying drawings, wherein, for purposes of illustration only, specific embodiments are set forth in detail.
BRIEF DESCRIPTION OF THE DRAWINGS [0012] FIG. 1 illustrates a known covered stent configuration. [0013] FIG. 2 illustrates a portion of another known covered stent configuration. [0014] FIG. 3A is a cut away view of a covered stent embodiment according to the invention with a portion of the cover removed to show a stent element and a substrate in which it is integrated.
[0015] FIG. 3B1 is a sectional view taken along line 3B1-3B1 in FIG. 3A and diagrammatically illustrating locations in the tubular substrate where the annular stent is interwoven.
[0016] FIG. 3B2 is a sectional view taken through a portion of one of the stents of FIG. 3A showing the substrate and cover material
[0017] FIG. 3C is a close up view illustrating a variation of the substrate-stent configuration shown in FIG. 3A.
[0018] FIG. 3D is a close up view illustrating another variation of the substrate-stent configuration shown in FIG. 3A.
[0019] FIG. 4 is a close up view illustrating a stent-graft substrate and a bare wire spring integrated therein according to another embodiment of the invention. [0020] FIG. 5A illustrates a known anchoring mechanism.
[0021] FIG. 5B illustrates a portion of a covered stent with the anchoring mechanism of FIG. 5A integrated therein.
[0022] FIG. 6 is a partial sectional view of a portion of a covered stent with an anchor element secured thereto.
[0023] FIG. 7 is a partial sectional view of a portion of a covered stent with an anchor element secured thereto.
[0024] FIGS. 8A and 8B illustrate assembly of another covered stent embodiment according to the invention, where FIG. 8A illustrates an anchoring attachment component for the covered stent and FIG. 8B illustrates the anchoring attachment component integrally formed in a covered stent according to another embodiment.
DETAILED DESCRIPTION
[0025] The following description will be made with reference to the drawings where when referring to the various figures, it should be understood that like numerals or characters indicate like elements. Further, when referring to catheters, delivery devices, and loaded fasteners described below, the proximal end is the end nearest the operator and the distal end is farthest from the operator.
[0026] The invention generally involves a method of incorporating one or more stent and/or anchor structures into a polymeric membrane, which can be formed, for example, through known electrospinning or dip coating techniques. The stent or stents or at least a portion thereof are integrally incorporated into a material, which can be referred to as a substrate, and the integrated construction partially or wholly encapsulated (e.g., in a polymer such as polyurethane) by known electrospinning or dip coating techniques.
[0027] According to one embodiment, the substrate material can be loose textile mesh constructed from an open weave, knit, or braid. The textile mesh should be sufficiently open to easily allow the polymer to flow through it during the electrospinning or dip coating process. In the case of wire stents, incorporating or integrating the stent into the substrate material can be accomplished by passing an end of the stent wire back and forth through mesh in an annular direction and then crimping the free ends of the wire together to form an annular stent element. All of the wire need not be weaved in and out of the mesh as will be described in more detail below. Other methods of integrating the stent and mesh material include weaving or knitting the mesh around the entire stent or at least a portion of the stent. The integrated stent-substrate construction is then encapsulated or coated using, for example, a known stent electrospinning or dip coating process, to form the polymeric membrane stent cover. The stent cover provides a fluid barrier that is suitable as for
use as a graft in a lumen in a human patient. Typically the cover will provide a continuous blood impervious surface suitable for use in an artery in a human patient. [0028] One of the many advantages of this construction is that if the stent becomes completely delaminated from the polymeric membrane formed with the foregoing process, it remains attached by the polymer mesh (polymer mesh is a loose weave, braid, or knit. Further, the substrate or mesh can better distribute the load of the stent through the membrane as compared to a stent without such a substrate. The polymeric material also can be selected to improve the bonding or adhesion between the stent-substrate and the polymeric material.
[0029] The mesh substrate has a loose construction suitable for weaving the stent wire in and out of the substrate. It can be a very open weave, knit or braid. Knitted meshes typically offer more flexibility and weaves typically offer more dimensional stability. The substrate mesh can be made from a variety of materials including polyester, UHMWPE, liquid crystal polymers, and Kevlar.
[0030] Referring to FIG. 3A, a covered stent according to one embodiment of the invention is shown in cut away view so that the substrate can be seen. In the illustrative example, covered stent 200 is shown with three stents 202a, 202b and 202c. It should be understood, however, that more or fewer stents can be used. The stents are shown with undulating annular configurations where each undulation has two leg portions which converge at an apex. The number of undulations can vary depending on the size of the stent and the application and in this example there are four undulations where two are hidden from view. In this embodiment, one of each of the two leg portions (of the undulating stent) is interwoven into the material and the other is not woven into the material and is adjacent to the inner surface or outer surface of mesh substrate 206. FIG. 3A depicts descending legs 208a and 208b interwoven in mesh substrate 206 in which appears as dashed lines, while ascending legs 209a and 209b are shown positioned along the outer surface of the substrate. The other undulating portions are similarly integrated with mesh substrate 206, but hidden from view. Thus, every other leg is interwoven into the substrate when moving in an annular or circumferential direction as diagrammatically shown in FIG. 3B1. In the variation shown in FIG. 3C, an oppositely configured pattern is used. Legs 209a, 209b, and 209c are interwoven into mesh substrate 206, while legs 208a, 208b, 208c are outside the mesh substrate prior to electrospinning or dip coating (the remaining legs forming the annular stent are hidden from view. In the variation shown in FIG. 3D, all legs of each undulation are interwoven into the mesh substrate before
electrospinning or dip coating (five legs are shown in this figure with the remaining legs forming the annular stent being hidden from view).
[0031] Referring to FIG. 3B2, a sectional view of a portion of stent 200 is shown depicting stent wire 202c between two layers of polymeric material 204 on opposite sides of the mesh substrate. A noted above, the mesh substrate is sufficiently open so as to allow the polymer to pass therethrough during the electrospinning or dip coating process.
[0032] Referring to FIG. 4, another embodiment is shown where undulating bare spring wire 510 is integrated with mesh substrate 506 before electrospinning or dip coating. The apex portions at one end of the bare spring are interwoven in mesh substrate 506. The apex portions are shown encircled and numbered 512a, 512b, and 512c. Stent elements can be provided as described in any of the embodiments disclosed herein.
[0033] Referring to FIGS. 5A and 5B, integration of an anchor into a covered stent will be described. FIG. 5A depicts a known stent-graft anchor 600 having a barb support member or cage 602 with a plurality of barbs 604a,b,c,d extending from or secured to end portions along one side thereof. Wires or posts 606a,b,c,d having eyelets or loops 608a,b,c,d at their free ends extend from or are attached to the other side of the cage. Referring to FIG. 5B, the anchor is secured to covered stent 650 having one or more stents 652 integrated therein using a substrate as described above. The anchor is secured to the substrate with a plurality of high strength filaments 654a,b...n that are looped through eyelets 608a,b...n. The filaments, each of which can be a high strength fiber, are interwoven in the substrate along a portion of the length of the substrate such as shown in detail in FIG. 6 before the stent, substrate and eyelets are encapsulated in a polymer by way of, for example, an electrospinning or dip coating process to provide a tubular covered stent that is impervious to blood flow through the tubular cover. The substrate can run the entire length of the covered stent in this embodiment or any other embodiment described herein and the filaments can be interwoven along the entire length of the substrate to maximize filament incorporation or integration with the cover or polymeric membrane 656, which can comprise, for example, any of the materials described above. However, the substrate need not run the entire length of the covered stent and the filaments need not extend the entire length of the substrate. In another embodiment, the free ends of the filament can be adhered, tied otherwise secured to the substrate. Anchor 600 and the bare springs described below typically are attached to the proximal end of the covered
stent, which is the end closest to the heart by reference to blood flow path when the covered stent is positioned in situ.
[0034] Referring to FIG. 6, another covered stent embodiment 700 is shown where a bare coil spring 750 with posts 752a,b,c...n extending therefrom and including eyelets 754a,b,c...n is secured to the covered stent in the same manner as anchor 600 is secured to covered stent 650. Each of a plurality of high strength filaments 756a,b...n, each of which can be a high strength fiber, are passed through a respective eyelet and interwoven in the mesh substrate that extends the entire length and the entire circumference of the covered stent. Covered stent 700 is shown in partial section with a portion of polymeric layer or cover 757 removed to show a portion of substrate 758 in an enlarged manner to illustrate filament 756b interwoven therein. Substrate 758 has a plurality of interwoven threads that can be interlaced like the warp and weft of a woven fabric. It should be understood that mesh patterns in all of the embodiments described herein are interchangeable and further that other patterns can be used as the illustrative embodiments are provided for the purposes of example and not to limit the scope of of possible options. Covered stent 700 also includes one or more stents 780 which can have the same configuration as stents 202a-c and can be interwoven into mesh substrate 758 in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206.
[0035] Referring to FIG. 7, another covered embodiment 800, which is the same as covered stent 700 with the exception that the securing filament pattern differs. Bare spring 850 can have the same construction as bare spring 750 with eyelets 854a,b,c...n through which high strength filaments 856a,b,c...n are passed. Filaments 856a, b, c... n are interwoven in substrate 858, which can have the same construction as substrate 758 or any other suitable substrate. Covered stent 800 is shown in partial section with a portion of polymeric layer or cover 857 removed to show a portion of substrate 858 in an enlarged manner to illustrate filaments 856a and 856c interwoven therein. In the illustrative embodiment, each filament has one portion that extends in a clockwise helical direction and another portion that extends in a counterclockwise helical direction. The filaments in this embodiment can improve load distribution from the eyelets. Although not shown, covered stent 800 also includes one or more stents, which can have the same configuration as stents 202a-c and can be interwoven into mesh substrate 858 in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206.
[0036] Referring to FIGS. 8A and 8B, another covered stent embodiment 900 according to the invention is shown, where FIG. 8A illustrates an anchor and attachment component of covered stent 900 and FIG. 8B illustrates the anchor and attachment component integrally formed in the covered stent using electrospinning or dip coating techniques. Referring to FIG. 8A, bare spring 950 has the same construction as bare spring 750 and includes eyelets 954a,b,c...n through which a single high strength filament 956 is passed. Filament 956, which can be a high strength fiber, is interwoven in annular substrate 958, which can have the same construction as substrate 758 or any other suitable substrate. Annular substrate 958 can then be coupled to a tubular substrate such as substrate 206. Covered stent 800 also includes one or more stents 980, which can have the same configuration as stents 202a-c and can be interwoven into the mesh substrate to which substrate 958 is coupled in the same manner as stents 202a-c are interwoven into braid-type mesh substrate 206. The stent, bare spring, and substrate assembly is then encapsulated with a polymer using any suitable process such as electrospinning or dip coating. [0037] Although not shown, any of the covered stents described herein can have a bifurcated configuration suitable for treating abdominal aortic aneurysms. [0038] Any feature described in any one embodiment described herein can be combined with any other feature or features of any of the other embodiments or features described herein. Furthermore, variations and modifications of the devices and methods disclosed herein will be readily apparent to persons skilled in the art.
Claims
1. A covered stent suitable for placement in a lumen in a human body comprising: a substrate; a stent adapted to be placed in a lumen of a human body, said stent having portions interwoven in said substrate; and encapsulation encapsulating said substrate and the portions of said stent interwoven in said substrate and forming a tubular graft member.
2. The covered stent of claim 1 wherein said substrate has a tubular shape.
3. The covered stent of claim 1 wherein said substrate extends less than the entire length of the tubular graft member.
4. The covered stent of claim 1 wherein said substrate extends the entire length of the tubular graft member.
5. The covered stent of claim 1 wherein said substrate comprises mesh material.
6. The covered stent of claim 5 wherein said encapsulation extends through the mesh material.
7. The covered stent of claim 1 wherein said encapsulation comprises polymeric material.
8. The covered stent of claim 7 wherein said encapsulation is formed through an electrospinning process.
9. The covered stent of claim 7 wherein said encapsulation is formed through s a dip coating process.
10. The covered stent of claim 1 including a plurality of said stents where each of said stents is interwoven in said substrate.
11. The covered stent of claim 1 wherein said tubular graft forms a wall that is impervious to blood flow therethrough.
12. The covered stent of claim 1 further including an anchor member and at least one filament, said filament extending through a portion of said anchor member and being interwoven in said substrate.
13. The covered stent of claim 1 wherein said anchor member has barbs extending therefrom.
14. The covered stent of claim 1 further including a bare spring and at least one filament, said filament extending through a portion of said bare spring and being interwoven in said substrate.
15. A covered stent suitable for placement in a lumen in a human body comprising: a substrate; a plurality of stents adapted to be placed in a lumen of a human body, said stents having portions interwoven in said substrate; and a tubular polymeric member covering said stents and extending through at least a portion of said substrate.
16. The covered stent of claim 15 wherein said substrate comprises mesh.
17. The covered stent of claim 15 further including an anchor and a filament secured to the anchor and said substrate.
18. The covered stent of claim 15 wherein said anchor comprises a bare spring element.
19. The covered stent of claim 15 wherein said anchor has a barb extending therefrom.
20. A method of making a covered stent comprising: interweaving a wire though a substrate to form a tubular member; encapsulating the tubular member to form a covered stent having a tubular cover suitable for placement in a lumen of a human body.
21. The method of claim 20 wherein encapsulating comprises electrospinning a polymer over the stent and substrate.
22. The method of claim 20 wherein encapsulating comprises dipping the stent and substrate in polymeric material.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/059,541 US20090248131A1 (en) | 2008-03-31 | 2008-03-31 | Covered Stent and Method of Making Same |
| PCT/US2009/035901 WO2009123814A1 (en) | 2008-03-31 | 2009-03-03 | Covered stent and method of making |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2271280A1 true EP2271280A1 (en) | 2011-01-12 |
Family
ID=40585128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP09728421A Withdrawn EP2271280A1 (en) | 2008-03-31 | 2009-03-03 | Covered stent and method of making |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20090248131A1 (en) |
| EP (1) | EP2271280A1 (en) |
| JP (1) | JP2011516156A (en) |
| WO (1) | WO2009123814A1 (en) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8795577B2 (en) | 2007-11-30 | 2014-08-05 | Cook Medical Technologies Llc | Needle-to-needle electrospinning |
| JP5300987B2 (en) | 2009-01-16 | 2013-09-25 | ゼウス インダストリアル プロダクツ, インコーポレイテッド | Electrospinning of PTFE containing high viscosity materials |
| US20130268062A1 (en) | 2012-04-05 | 2013-10-10 | Zeus Industrial Products, Inc. | Composite prosthetic devices |
| JP5456892B2 (en) | 2009-08-07 | 2014-04-02 | ゼウス インダストリアル プロダクツ インコーポレイテッド | Multilayer composite |
| US8637109B2 (en) * | 2009-12-03 | 2014-01-28 | Cook Medical Technologies Llc | Manufacturing methods for covering endoluminal prostheses |
| US8808353B2 (en) | 2010-01-30 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds having a low crossing profile |
| US8568471B2 (en) | 2010-01-30 | 2013-10-29 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
| US8512393B2 (en) * | 2010-02-26 | 2013-08-20 | ProMed, Inc. | Apparatus for vessel access closure |
| US9345602B2 (en) | 2010-09-23 | 2016-05-24 | Abbott Cardiovascular Systems Inc. | Processes for making crush recoverable polymer scaffolds |
| CN102782196A (en) | 2010-10-14 | 2012-11-14 | 宙斯工业产品股份有限公司 | Antimicrobial Substrate |
| CN103561682A (en) * | 2011-01-28 | 2014-02-05 | 梅瑞特医药体系股份有限公司 | Electrospun PTFE coated stents and methods of use thereof |
| US9114000B2 (en) | 2011-03-14 | 2015-08-25 | Cook Medical Technologies Llc | Apparatus and methods to enhance bonding in endoluminal prostheses |
| US9060852B2 (en) | 2011-04-08 | 2015-06-23 | Cook Medical Technologies Llc | Method for making a flexible stent-graft |
| US9173736B2 (en) * | 2011-04-28 | 2015-11-03 | Medtronic Vascular, Inc. | Method of making an endoluminal vascular prosthesis |
| US8726483B2 (en) | 2011-07-29 | 2014-05-20 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
| US20150230918A1 (en) | 2011-08-16 | 2015-08-20 | The University Of Kansas | Biomaterial based on aligned fibers, arranged in a gradient interface, with mechanical reinforcement for tracheal regeneration and repair |
| US20130289690A1 (en) * | 2011-11-01 | 2013-10-31 | Hira V. Thapliyal | Personalized prosthesis and methods of use |
| US9175427B2 (en) | 2011-11-14 | 2015-11-03 | Cook Medical Technologies Llc | Electrospun patterned stent graft covering |
| KR102037543B1 (en) | 2012-01-16 | 2019-10-28 | 메리트 메디컬 시스템즈, 인크. | Rotational spun material covered medical appliances and methods of manufacture |
| US8911490B2 (en) * | 2012-03-27 | 2014-12-16 | Medtronic Vascular, Inc. | Integrated mesh high metal to vessel ratio stent and method |
| US9192462B2 (en) | 2012-04-06 | 2015-11-24 | Trivascular, Inc. | Low profile stent graft and delivery system |
| EP2833829B1 (en) * | 2012-04-06 | 2019-11-06 | TriVascular, Inc. | Low profile stent graft and delivery system |
| US9254212B2 (en) | 2012-04-06 | 2016-02-09 | Abbott Cardiovascular Systems Inc. | Segmented scaffolds and delivery thereof for peripheral applications |
| US8834556B2 (en) | 2012-08-13 | 2014-09-16 | Abbott Cardiovascular Systems Inc. | Segmented scaffold designs |
| US11541154B2 (en) | 2012-09-19 | 2023-01-03 | Merit Medical Systems, Inc. | Electrospun material covered medical appliances and methods of manufacture |
| US9198999B2 (en) | 2012-09-21 | 2015-12-01 | Merit Medical Systems, Inc. | Drug-eluting rotational spun coatings and methods of use |
| US10154918B2 (en) | 2012-12-28 | 2018-12-18 | Cook Medical Technologies Llc | Endoluminal prosthesis with fiber matrix |
| US9827703B2 (en) | 2013-03-13 | 2017-11-28 | Merit Medical Systems, Inc. | Methods, systems, and apparatuses for manufacturing rotational spun appliances |
| WO2014159710A1 (en) | 2013-03-13 | 2014-10-02 | Merit Medical Systems, Inc. | Serially deposited fiber materials and associated devices and methods |
| CN105213076A (en) * | 2014-06-12 | 2016-01-06 | 微创心脉医疗科技(上海)有限公司 | A kind of artificial tumor neck and preparation method thereof |
| EP3261589B1 (en) | 2015-02-26 | 2020-09-16 | Merit Medical Systems, Inc. | Layered medical appliances |
| EP3285687A4 (en) | 2015-04-22 | 2019-07-10 | AneuMed, Inc. | PERSONALIZED PROSTHESIS AND DEPLOYMENT METHODS |
| KR102038317B1 (en) * | 2017-11-21 | 2019-10-30 | 주식회사 티티엔지 | Golf cart system capable of autonomous travel based on accurate position information and golf cart control method using the system |
| EP4297813A4 (en) | 2021-02-26 | 2025-01-15 | Merit Medical Systems, Inc. | FIBROUS CONSTRUCTIONS WITH THERAPEUTIC MATERIAL PARTICLES |
| WO2023125434A1 (en) * | 2021-12-31 | 2023-07-06 | 元心科技(深圳)有限公司 | Covered stent system and preparation method therefor |
| CN116687634B (en) * | 2023-07-24 | 2023-11-03 | 上海宏普医疗器械有限公司 | Puncture tectorial membrane support that ultrasonic wave was carried down |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69433617T2 (en) * | 1993-09-30 | 2005-03-03 | Endogad Research Pty Ltd. | INTRALUMINAL TRANSPLANT |
| DE69732794T2 (en) * | 1996-01-05 | 2006-04-06 | Medtronic, Inc., Minneapolis | EXPANDABLE ENDOLUMINARY PROSTHESIS |
| US6156064A (en) * | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
| US6159239A (en) * | 1998-08-14 | 2000-12-12 | Prodesco, Inc. | Woven stent/graft structure |
| US6849088B2 (en) * | 1998-09-30 | 2005-02-01 | Edwards Lifesciences Corporation | Aorto uni-iliac graft |
| US6368345B1 (en) * | 1998-09-30 | 2002-04-09 | Edwards Lifesciences Corporation | Methods and apparatus for intraluminal placement of a bifurcated intraluminal garafat |
| EP1121066B1 (en) * | 1999-01-22 | 2006-05-17 | Gore Enterprise Holdings, Inc. | Covered endoprosthesis |
| US6287335B1 (en) * | 1999-04-26 | 2001-09-11 | William J. Drasler | Intravascular folded tubular endoprosthesis |
| DE20115706U1 (en) * | 2001-09-25 | 2001-12-13 | Curative Ag | Arrangement for implantation in an aorta |
| US7708771B2 (en) * | 2002-02-26 | 2010-05-04 | Endovascular Technologies, Inc. | Endovascular graft device and methods for attaching components thereof |
| WO2003087443A1 (en) * | 2002-04-11 | 2003-10-23 | Secant Medical, Inc. | Covering process using electrospinning of very small fibers |
| US20050008588A1 (en) * | 2003-06-05 | 2005-01-13 | L'oreal | Aminoarylvinyl-s-triazine compounds and uses thereof |
| US7192440B2 (en) * | 2003-10-15 | 2007-03-20 | Xtent, Inc. | Implantable stent delivery devices and methods |
| WO2005070337A2 (en) * | 2004-01-20 | 2005-08-04 | Cook Incorporated | Endoluminal stent graft with sutured attachment |
| US8172895B2 (en) * | 2005-08-18 | 2012-05-08 | Cook Medical Technologies Llc | Design and assembly of fenestrated stent grafts |
| US20080306580A1 (en) * | 2007-02-05 | 2008-12-11 | Boston Scientific Scimed, Inc. | Blood acess apparatus and method |
-
2008
- 2008-03-31 US US12/059,541 patent/US20090248131A1/en not_active Abandoned
-
2009
- 2009-03-03 WO PCT/US2009/035901 patent/WO2009123814A1/en not_active Ceased
- 2009-03-03 JP JP2011503007A patent/JP2011516156A/en active Pending
- 2009-03-03 EP EP09728421A patent/EP2271280A1/en not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2009123814A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20090248131A1 (en) | 2009-10-01 |
| WO2009123814A1 (en) | 2009-10-08 |
| JP2011516156A (en) | 2011-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090248131A1 (en) | Covered Stent and Method of Making Same | |
| US10159560B2 (en) | Prosthesis having pivoting fenestration | |
| EP2499997B1 (en) | Endoluminal prostheses | |
| US10265200B2 (en) | Medical prostheses having bundled and non-bundled regions | |
| EP0880949B1 (en) | Bifurcated stent graft | |
| US9173736B2 (en) | Method of making an endoluminal vascular prosthesis | |
| JP7223703B2 (en) | Multi-layered endoluminal prosthesis assembly and manufacturing method | |
| US20120221096A1 (en) | Prosthesis having pivoting fenestration | |
| WO2010024849A1 (en) | Prosthesis with moveable fenestration | |
| JP2012040394A (en) | Prosthesis having pivoting fenestration | |
| CN103908356A (en) | Prosthesis having pivoting fenestration | |
| US11690705B2 (en) | Graft having a pocket for receiving a stent and woven graft material, forming a pocket | |
| JP7774045B2 (en) | Vascular stent graft | |
| WO2013130390A1 (en) | Prosthesis | |
| CN119365150A (en) | Sutureless stent graft with integrated extension and stent graft structure and method of forming the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20101028 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20110616 |